High-pressure mixing, precision fluid handling, software-defined control, and in-line measurement provide the technical foundation for reproducible formulation and synthesis systems.
Our technical architecture connects equipment, software, process definition, measurement, and downstream handling rather than treating them as separate layers.
Lipid nanoparticles form when lipid and aqueous streams meet under controlled conditions. Flow stability, phase ratio, mixer geometry, composition, and quench timing influence particle formation and reproducibility.
A complete process links fluid handling, sensing, automation, purification, analytics, and material transfer into an environment that can be understood and reproduced.
Recipe control, coordinated actuation, process data, and system diagnostics allow operating conditions to be defined and repeated across development cycles.
Solid-phase synthesis converts a molecular sequence into a repeatable fluidic programme. Reagent routing, contact time, washing, pressure, and in-line measurement determine how consistently each reaction cycle is executed.
Nanoparticle formation occurs rapidly. The equipment surrounding the mixer exists to define the conditions under which that self-assembly takes place and to stabilise the product immediately afterwards.
Lipid components are prepared in an organic solvent, commonly ethanol.
The biomolecular payload is prepared in a compatible aqueous buffer.
Defined streams meet in a mixer; the solvent shift drives lipid self-assembly around the payload.
Controlled dilution limits further particle growth and reduces the solvent concentration.
Buffer exchange, concentration, filtration, and analytical control prepare the formulation for its next stage.
Tighter integration between instrumentation and software supports consistent recipe execution, clearer diagnostics, and process records that can be compared across development work.
Development programme 02 applies the same equipment-led approach to automated oligonucleotide synthesis. In solid-phase synthesis, bases are added sequentially to a growing chain immobilised on a support, with each cycle delivered in a defined order and under controlled conditions.
A protecting group is removed to expose the reactive site for the next base addition.
The next phosphoramidite is delivered to the solid support and coupled to the growing sequence.
The newly formed linkage is converted into its stable phosphate or phosphorothioate form.
Unreacted chains are capped and the flow path is washed before the cycle repeats.
Repeatable synthesis depends on accurate metering, chemically compatible flow paths, controlled contact times, effective washing, and measurement capable of showing whether each cycle is performing as intended.